Skip to main content

Global Point of Care (PoC) Imaging Devices Market to Reach $19.84 Billion by 2030

 According to a new market intelligence report by BIS Research titled “Global Point of Care imaging devices Market – Analysis & Forecast 2020-2030”, The global point of care (PoC) imaging devices market was valued at $8.66 billion in 2019 and is expected to reach $19.84 billion by the end of 2030, clocking a CAGR of 8.70%, during the forecast period.

BIS Research Report -  https://bisresearch.com/industry-report/point-of-care-imaging-devices-market.html

The diagnostic imaging technology ecosystem is facing significant changes in its market dynamics as new methodologies, technologies, and practices are currently being introduced in the market. The ecosystems are going through a period of amendments, driven by increasing demand for emerging technologies and its adoption in the healthcare sector. Several other factors ranging rising aging population to secure economic development in the emerging nations too are driving the growth of the PoC imaging devices market.

Request for a Sample:  https://bisresearch.com/requestsample?id=952&type=download

Some of the key drivers for the growth of the point of care (PoC) imaging devices market include growing need for more patient convenience, increased healthcare spending by countries to ramp up their healthcare infrastructure, and higher preference due to economic consideration.

PoC imaging devices are aimed at ensuring minimum inconvenience for patients. Thus, point of care imaging devices can be used at a patient’s bedside. The places include hospitals, ambulatory surgical centers, and also their homes. The use of handheld devices allows the scan to be performed at the patients’ homes, reducing or eliminating the need for hospital visits and is particularly useful for elderly patients. Furthermore, the use of handheld PoC enabled devices is now more relevant due to the ongoing COVID-19 pandemic.

The PoC imaging devices market comprises some of the leading players in the medical imaging ecosystem. These include Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Shimadzu Corporation, Fujifilm Holdings Corporation, Samsung Electronics Co., Ltd., Canon Inc., and Digirad Corporation, among others. Additionally, there has been an increasing number of start-ups in the market which are gaining prominence or are expected to launch their product soon, including Butterfly Network, Inc., Hyperfine Research, and Perimeter Medical Imaging, among others.

 

The answers to the following key questions can be derived from this report:

·         What are the key regulations governing the Point-of-Care (PoC) Imaging devices market?

·         What are the key technological developments on which the current industry leaders are spending a major share of their R&D investment?

·         How is the role of PoC imaging devices expected to evolve in the future?

·         What level of impact will the COVID-19 crisis have on the market in terms of change in demand and the functioning of the supply chain?

·         Which leading players are holding a major share of the PoC imaging devices market?

·         What are the current business models and key strategies adopted by leading players, and how likely are those models to persist in future market scenarios?

Comments

Popular posts from this blog

Pharmacogenomics Services Market Dynamics, Competitive Landscape & Forecast to 2031

  BIS healthcare experts have found the pharmacogenomics services industry to be one of the most rapidly evolving and dynamic markets. The global  pharmacogenomics services market  is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031. The market is driven by certain factors, including increasing prevalence of infectious diseases and various types of cancer, increasing adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogenomics for drug discovery and development. Currently, the pharmacogenomics services industry is witnessing an upsurge due to the increasing prevalence of infectious diseases and various types of cancer, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogen...

Oncolytic Virus Therapies Market is projected to grow at a whopping CAGR of 26.28% over the period 2020-2030

  The global oncolytic virus therapies market is undergoing a significant flux with regard to the advancements that have already taken place and are currently invading the market space. Additionally, with the emergence of virus therapeutics, there is an immense potential for these emerging sub-markets to continue fueling the overall oncolytic virus therapies market. This chapter reviews the significant drivers and restraints that are considerably impacting the dynamicity of the global oncolytic virus therapies market. Due to the ever-rising incidence of cancers, the need for better products and services is becoming more evident. Several key players are aligning their technologies as per the market requirements to provide technologically advanced products and services by adopting inorganic strategies such as agreements, partnerships, and collaborations. The global oncolytic virus therapies market is projected to grow at a whopping CAGR of 26.28% over the period 2020-2030 and reach ...

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applic...